课题基金 / 基金详情

Pathological differences in oseoporosis following menopause or oophorectomy

Pathological differences in oseoporosis following menopause or oophorectomy
绝经或卵巢切除术后骨质疏松症的病理学差异
批准号:
04671019
负责人:
OHTA Hiroaki
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993

项目摘要

项目成果

OHTA Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
分析绝经后骨质疏松症与卵巢切除术后骨质疏松症的病理学差异。对绝经或卵巢切除后平均3年的受试者进行了研究。绝经后受试者的雄烯二酮和雌激素水平明显高于卵巢切除者。然而,绝经期受试者的类固醇优势并没有反映在骨代谢中。两个受试者组之间通过任何测定方法(MD、QCT、DPA、DXA)或任何测量部位(外周骨/中轴骨、横骨/皮质骨)检测到BMD无显著性差异。因此,临床上认为与卵巢切除相关的骨质疏松症,引起骨的剧烈变化,与绝经后的生理现象骨质疏松症相当。然而,绝经期妇女的临床异质性可能掩盖了绝经和卵巢切除后骨反应的个体差异。因此,体外研究是必要的,虽然只有初步的结果,我们已经注意到定量和定性的差异,骨髓细胞卵巢切除术的反应。这些发现将在未来的研究中得到进一步的研究。
英文摘要
Enodocinological dynamics, bone metabolism and bone mineral density (BMD) were and analyzed to study whether or not there aer pathological differences in osteoporosis following menopause and that following oophorectomy. Subjects in whom a mean period of 3 years had passed since menopause or oophorectomy, a time when effects on vone metabolism should be evident, were studied, Levels of androstenedione and e_1, considered to have a fanorable effect on bone matabolism, were significantly higher in menopausal subjects compared with subjects undergoing oopherectomy. Howeever, steroid dominance in the menopausal subjects was not reflected in bone metabolism. Nosignificant dirrerence in BMD was detected between the two subject groups by any determination method (MD, QCT, DPA, DXA) or for any site measured (peripheral bone/axial bone, travecular bone/cortical bone). Therefore, osteoporesis associated with oophorectomy, causing drastic changes in bone, ws clinically considered to be comparable to osteoporosis associated with the physiological phenomenon if menopause. However, clinical heterogeneity in junan subjects may mask fine individual differences in the response of bone to menopause and oophorectomy. Invitro research is therefore necessary, Although only preliminary results are available, we have noted quantitative and qualitative differnces in the response of bone marrow cells to oophorectomy. These findings will be followed up by future reseatch.
期刊论文(102)
专著(0)
科研奖励(0)
会议论文
太田博明: "更年期から老年期へ オステオポローシス-治療薬剤の選択と現時点での評価-" 臨床婦人科産科. 46. 959-962 (1992)
Hiroaki Ota:“从绝经期到老年的骨质疏松症 - 治疗药物的选择和当前评估”临床妇产科 46. 959-962 (1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
太田博明: "特集/産婦人科における痛み-鑑別と対策-[婦人科]中高年の腰痛" 産婦人科の実際. 41. 1671-1676 (1992)
太田弘明:《专题/妇产科疼痛-辨证与对策-【妇科】中老年人腰痛》妇产科实践41。1671-1676(1992)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
太田博明: "閉経と卵巣全摘出はどちらが骨粗鬆症のよりrisk factorか?" 日産婦関東連合地方部会会報. 30. 67-70 (1993)
Hiroaki Ota:“骨质疏松症、绝经或全卵巢切除术哪个风险因素更大?”日产妇女联盟关东地方小组委员会公告 30. 67-70 (1993)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroaki Ohta: "Osteoporosis-Selection and evaluation of drug-" Clin Gynecol Obstet. 46. 959-962 (1992)
Hiroaki Ohta:“骨质疏松症-药物的选择和评价-”Clin Gynecol Obstet。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 46 条
    Raloxifene in the Mechanism of Bone Metabolism
    • 批准号:
      12671631
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2000
    • 负责人:
      OHTA Hiroaki
    • 依托单位:
    Joint research on a technique of LODERS imaging.
    Estrogen in the Mechanism of Bone Metabolism
    • 批准号:
      09671715
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1997
    • 负责人:
      OHTA Hiroaki
    • 依托单位:
    Pathological differences in osteoprosis following menopause or oophorectomy-Analysis of animal models and in vitro-
    • 批准号:
      06671684
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1994
    • 负责人:
      OHTA Hiroaki
    • 依托单位:
    海外基金